Your browser doesn't support javascript.
loading
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel.
Hoogland, Aasha I; Jayani, Reena V; Collier, Aaron; Irizarry-Arroyo, Nathaly; Rodriguez, Yvelise; Jain, Michael D; Booth-Jones, Margaret; Hyland, Kelly A; James, Brian W; Barata, Anna; Bachmeier, Christina A; Chavez, Julio C; Khimani, Farhad; Krivenko, Gabriel S; Lazaryan, Aleksandr; Liu, Hien D; Nishihori, Taiga; Pinilla-Ibarz, Javier; Shah, Bijal D; Abidi, Muneer; Locke, Frederick L; Jim, Heather S L.
Affiliation
  • Hoogland AI; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Jayani RV; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology/Oncology, Nashville, TN, USA.
  • Collier A; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Irizarry-Arroyo N; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Rodriguez Y; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Jain MD; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Booth-Jones M; Moffitt Cancer Center, Department of Supportive Care Medicine, Tampa, FL, USA.
  • Hyland KA; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • James BW; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Barata A; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
  • Bachmeier CA; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Chavez JC; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
  • Khimani F; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Krivenko GS; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Lazaryan A; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Liu HD; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Nishihori T; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Pinilla-Ibarz J; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
  • Shah BD; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
  • Abidi M; Spectrum Health Cancer Center, Michigan State University, Grand Rapids, MI, USA.
  • Locke FL; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
  • Jim HSL; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Cancer Med ; 10(6): 1936-1943, 2021 03.
Article in En | MEDLINE | ID: mdl-33641257

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Antigens, CD19 / Patient Reported Outcome Measures Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Antigens, CD19 / Patient Reported Outcome Measures Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2021 Document type: Article Affiliation country: Country of publication: